These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26091454)

  • 1. HIV-1 Treatment-as-Prevention: A Cohort Study Analysis of Serodiscordant Couples in Rural Southwest China.
    Tang Z; Lan G; Chen YQ; Zhu Q; Yang X; Shen Z; Chen Y; Zhang H; Kan W; Xing H; Ruan Y; Shao Y
    Medicine (Baltimore); 2015 Jun; 94(24):e902. PubMed ID: 26091454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
    Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
    AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.
    Jia Z; Mao Y; Zhang F; Ruan Y; Ma Y; Li J; Guo W; Liu E; Dou Z; Zhao Y; Wang L; Li Q; Xie P; Tang H; Han J; Jin X; Xu J; Xiong R; Zhao D; Li P; Wang X; Wang L; Qing Q; Ding Z; Chen RY; Liu Z; Shao Y
    Lancet; 2013 Oct; 382(9899):1195-203. PubMed ID: 23206835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa.
    Oldenburg CE; Bärnighausen T; Tanser F; Iwuji CC; De Gruttola V; Seage GR; Mimiaga MJ; Mayer KH; Pillay D; Harling G
    Clin Infect Dis; 2016 Aug; 63(4):548-54. PubMed ID: 27208044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterosexual transmission of HIV and related risk factors among serodiscordant couples in Henan province, China.
    Wang L; Wang L; Smith MK; Li LM; Ming S; Lü J; Cao WH; He WS; Zhou JP; Wang N
    Chin Med J (Engl); 2013; 126(19):3694-700. PubMed ID: 24112166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment to Prevent HIV Transmission in Serodiscordant Couples in Henan, China, 2006 to 2012.
    Smith MK; Westreich D; Liu H; Zhu L; Wang L; He W; Zhou J; Miller WC; Cohen MS; Wang N
    Clin Infect Dis; 2015 Jul; 61(1):111-9. PubMed ID: 25770173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factor Associated with Negative Spouse HIV Seroconversion among Sero-Different Couples: A Nested Case-Control Retrospective Survey Study in 30 Counties in Rural China.
    Tang H; Wu Z; Mao Y; Cepeda J; Morano J
    PLoS One; 2016; 11(10):e0164761. PubMed ID: 27741292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
    Anglemyer A; Rutherford GW; Baggaley RC; Egger M; Siegfried N
    Cochrane Database Syst Rev; 2011 Aug; (8):CD009153. PubMed ID: 21833973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of antiviral therapy on prevention of HIV transmission among sero-discordant couples in Guangxi Zhuang autonomous region].
    Zhu Q; Yang X; Jiang H; Tan G; Xiong R; Liao L; Xing H; Ruan Y; Shen Z; Tang Z; Shao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1401-5. PubMed ID: 26850400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China.
    He N; Duan S; Ding Y; Rou K; McGoogan JM; Jia M; Yang Y; Wang J; Montaner JS; Wu Z;
    PLoS One; 2013; 8(11):e77981. PubMed ID: 24236010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of factors associated with antiretroviral therapy intiation and its timeliness among HIV sero-discordant couples in high HIV prevalence regions, China].
    Li J; Mao Y; Tang H; Han J; Xu J; Wu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jul; 49(7):625-31. PubMed ID: 26310476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
    Cohen MS; Chen YQ; McCauley M; Gamble T; Hosseinipour MC; Kumarasamy N; Hakim JG; Kumwenda J; Grinsztejn B; Pilotto JH; Godbole SV; Chariyalertsak S; Santos BR; Mayer KH; Hoffman IF; Eshleman SH; Piwowar-Manning E; Cottle L; Zhang XC; Makhema J; Mills LA; Panchia R; Faesen S; Eron J; Gallant J; Havlir D; Swindells S; Elharrar V; Burns D; Taha TE; Nielsen-Saines K; Celentano DD; Essex M; Hudelson SE; Redd AD; Fleming TR;
    N Engl J Med; 2016 Sep; 375(9):830-9. PubMed ID: 27424812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.
    Bavinton BR; Pinto AN; Phanuphak N; Grinsztejn B; Prestage GP; Zablotska-Manos IB; Jin F; Fairley CK; Moore R; Roth N; Bloch M; Pell C; McNulty AM; Baker D; Hoy J; Tee BK; Templeton DJ; Cooper DA; Emery S; Kelleher A; Grulich AE;
    Lancet HIV; 2018 Aug; 5(8):e438-e447. PubMed ID: 30025681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "I just believe there is a risk" understanding of undetectable equals untransmissible (U = U) among health providers and HIV-negative partners in serodiscordant relationships in Kenya.
    Ngure K; Ongolly F; Dolla A; Awour M; Mugwanya KK; Irungu E; Mugo N; Bukusi EA; Morton J; Odoyo J; Wamoni E; Barnabee G; Peebles K; O'Malley G; Baeten JM;
    J Int AIDS Soc; 2020 Mar; 23(3):e25466. PubMed ID: 32144888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
    Anglemyer A; Rutherford GW; Horvath T; Baggaley RC; Egger M; Siegfried N
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD009153. PubMed ID: 23633367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.
    Idoko J; Folayan MO
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):127-34. PubMed ID: 26050385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
    Anglemyer A; Rutherford GW; Egger M; Siegfried N
    Cochrane Database Syst Rev; 2011 May; (5):CD009153. PubMed ID: 21563172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early antiretroviral therapy on reducing HIV transmission in China: strengths, weaknesses and next focus of the program.
    Liu P; Tang Z; Lan G; Zhu Q; Chen H; You Y; Yang X; Liang S; Chen Y; Xing H; Liao L; Feng Y; Shen Z; Ruan Y; Shao Y
    Sci Rep; 2018 Feb; 8(1):3431. PubMed ID: 29467460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.